CHAI supports national governments to expand high-quality care and treatment to people living with HIV/AIDS.
February 25, 2015
CHAI and partners expand Hispaniola malaria elimination efforts
The U.S. Centers for Disease Control and Prevention (CDC) is leading a consortium of malaria partners aiming to eliminate indigenous cases of malaria on the island of Hispaniola by 2020.
February 26, 2015
CHAI Family Planning Market Report: May 2015
In 2019, updates to historical datasets were made upon consultation with relevant current suppliers, including the addition of a new supplier’s data. Please find the most up-to-date report here. The 2015 Family Planning Market Report can be found below.
April 1, 2015
Donor Disclosure Policy Q&A
Clinton Health Access Initiative, Inc. Donor Disclosure Policy – Q & A April 16, 2015 Q: Why is CHAI’s policy different from the Clinton Foundation’s policy? CHAI is an independent 501c3 charitable organization, separate from the Clinton Foundation. CHAI operates in over 30 countries and has nearly 1,500 employees, over 80 percent of whom are…
May 26, 2015
ViiV Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic dolutegravir by Aurobindo Pharma for the treatment of HIV
ViiV Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic dolutegravir by Aurobindo Pharma for the treatment of HIV London, May 26, 2015 – ViiV Healthcare, Aurobindo Pharma, and the Clinton Health Access Initiative, Inc. (CHAI) announced today that Aurobindo Pharma has submitted an Abbreviated New Drug Application (ANDA)…
July 16, 2015
“Big Data” Helping to Inform Big Decisions
CHAI’s Research and Development (R&D) Team works from a unique angle to support CHAI’s ambitions to improve patient outcomes in low- and middle-income countries. In particular, the team works to: 1. Identify, develop, validate, and transfer for manufacture and distribution better and less expensive drug formulations of existing HIV/AIDS, tuberculosis (TB), and malaria medicines; 2….
July 19, 2015
Breakthrough global agreement sharply lowers price of early infant diagnosis of HIV
CHAI and global partners in the Diagnostics Access Initiative have joined with Roche Diagnostics to announce a 35 percent reduction in the price for HIV early infant diagnostic technologies. The new access price is US$9.40 per test, including proprietary reagents and consumables associated with diagnosing HIV in very young children. Learn more here.
July 28, 2015
World Hepatitis Day 2015
Viral hepatitis is a major public health problem throughout the world, killing more people every year than HIV.(i) Hepatitis C is a viral disease transmitted through infected bodily fluids and attacks the liver, slowly scarring the organ until the person acquires liver cancer or faces a number of other renal or hepatic conditions that diminish…
August 11, 2015
Case Study: Resource Mapping in Malawi
Achieving universal access to HIV treatment requires using the resources available as efficiently as possible. To this end, CHAI supports 10 countries to conduct annual resource mapping. In Malawi, results have informed the allocation of US$300 million to high-impact interventions and increased national ownership of the HIV response. Learn more about CHAI’s work improving efficiency…
August 11, 2015
Case Study: Expanding Access to Contraceptive Implants
CHAI and partners achieved a price reduction agreement for contraceptive implants that increased total implant distribution by 56 percent from 2012 to 2013 and will result in procurement savings of more than US$300 million over six years. Learn more about this agreement to expand access to contraceptive implants and improve women’s choice and well-being in…